Topical 10% Povidone-Iodine in Preventing White Spots
Active_not_recruiting
Phase 2
Interventional Study
White Spot Lesions
Gingival Inflammation and Bleeding
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 10 – 17
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 80 (estimated)
- Sponsor
- University of Washington · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if topical application on the all surface of 10% Povidone Iodine (Povi-One) in healthy participants in transitional or permanent dentition (10-17 y) prevents new white spot lesions in the maxillary anterior teeth at 1 year of follow-up.
Researchers will compare Povi-One to a placebo to see if Povi-One works to prevent new white spot lesions.
It will al…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Healthy children and teens (10-17 years old)
* Transitional or permanent dentition of at least 4 permanent anterior teeth in each arch
* Full fixed appliance orthodontic treatment is expected to last at least one year
Exclusion Criteria:
* Allergies to iodine
* Chronic proph…
Contacts
No contact information available.